Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions
Novel mouse model of myotonic dystrophy displays reversible cardiac disease features of the condition
Myotonic dystrophy - Wikipedia
Epigenetics and Myotonic Dystrophy Type 1 | Encyclopedia MDPI
RNA toxicity model for DM1 pathogenesis and potential therapeutic... | Download Scientific Diagram
Myotonic dystrophy: Emerging mechanisms for DM1 and DM2 - ScienceDirect
Figure 1 from Myotonic Dystrophy Type 1 (DM1): From the Genetics to Molecular Mechanisms | Semantic Scholar
Myopathies without EOM Weakness: Facioscapulohumeral + Myotonic Dystrophy
New myotonic dystrophy type 1 mouse model | Cell Research
Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1: Molecular Therapy
Additional molecular pathogenetic mechanisms in DM1. Results suggest an... | Download Scientific Diagram
Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1 | Gene Therapy
Myotonic Dystrophy Testing & Diagnosis | Myotonic Dystrophy Foundation
IJMS | Free Full-Text | Disrupting the Molecular Pathway in Myotonic Dystrophy
Projects
DM1 pathogenetic mechanisms and therapeutic strategies. The actions of... | Download Scientific Diagram
RNA toxic gain-of-function model for DM1 pathogenesis. Mutant DMPK RNA... | Download Scientific Diagram
Myotonic Dystrophy Type 1 (DM1) – Kate Therapeutics
Strategies for DM1 gene therapy. A) Degradation of mutant RNA by... | Download Scientific Diagram
Myotonic dystrophy — Knowledge Hub
IJMS | Free Full-Text | Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing
Ligand for Potential Treatment of Myotonic Dystrophy Type 1 (DM1) | UIUC Office of Technology Management
